Patients  	Patients  	 NNS	O
with  	with  	 IN	O
isolated  	isolated  	 VBN	O
prolonged  	prolonged  	 VBN	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
bleeding  	bleeding  	 NN	I-NP
time 	time 	 NN	I-NP
.  	.  	 .	O
Clinical  	Clinical  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
In  	In  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
isolated  	isolated  	 VBN	O
prolonged  	prolonged  	 VBN	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
bleeding  	bleeding  	 NN	I-NP
time  	time  	 NN	I-NP
there  	there  	 EX	O
is  	is  	 VBZ	O
no  	no  	 DT	O
standardised  	standardised  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
concept 	concept 	 NN	I-NP
.  	.  	 .	O
With  	With  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
we  	we  	 PRP	O
characterized  	characterized  	 VBD	O
the  	the  	 DT	O
extent  	extent  	 NN	O
of  	of  	 IN	O
bleeding  	bleeding  	 VBG	B-NP
symptoms 	symptoms 	 NNS	I-NP
.  	.  	 .	O
All  	All  	 DT	O
diagnoses  	diagnoses  	 NN	O
known  	known  	 VBN	O
to  	to  	 TO	O
cause  	cause  	 VB	O
prolonged  	prolonged  	 VBN	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
bleeding  	bleeding  	 NN	I-NP
time  	time  	 NN	I-NP
( 	( 	 -LRB-	O
PFA-100 	PFA-100 	 NNP	B-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
epinephrine-cartridge  	epinephrine-cartridge  	 NNP	B-NP
> 	> 	 CD	O
160  	160  	 CD	O
s 	s 	 NN	O
,  	,  	 ,	O
ADP-cartridge  	ADP-cartridge  	 JJ	B-NP
>  	>  	 CD	O
120  	120  	 CD	O
s 	s 	 CD	O
)  	)  	 -RRB-	O
have  	have  	 VBP	O
been  	been  	 VBN	O
excluded 	excluded 	 VBN	O
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
platelet  	platelet  	 JJ	B-NP
function  	function  	 NN	I-NP
disorders 	disorders 	 NNS	I-NP
,  	,  	 ,	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
medications 	medications 	 NN	O
,  	,  	 ,	O
nutrition  	nutrition  	 NN	O
or  	or  	 CC	O
von  	von  	 NNP	B-NP
Willebrand  	Willebrand  	 NNP	I-NP
disease.  	disease.  	 CD	I-NP
75  	75  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
77 	77 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
n  	n  	 VBG	O
=  	=  	 SYM	O
58  	58  	 CD	O
women 	women 	 NNS	O
;  	;  	 :	O
23 	23 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
n  	n  	 VBG	O
=  	=  	 SYM	O
17  	17  	 CD	O
men 	men 	 NNS	O
,  	,  	 ,	O
median  	median  	 JJ	B-NP
age  	age  	 NN	I-NP
46  	46  	 CD	O
( 	( 	 -LRB-	O
16-81 	16-81 	 NNP	O
)  	)  	 -RRB-	O
years  	years  	 NNS	O
were  	were  	 VBD	O
included 	included 	 VBN	O
.  	.  	 .	O
All  	All  	 DT	O
bleeding  	bleeding  	 JJ	O
symptoms  	symptoms  	 NNS	B-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
stored  	stored  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
databank  	databank  	 NN	B-NP
with  	with  	 IN	O
help  	help  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
comprehensive  	comprehensive  	 JJ	B-NP
questionnaire.  	questionnaire.  	 CD	I-NP
78 	78 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
54 	54 	 CD	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
all  	all  	 DT	O
patients  	patients  	 NNS	O
reported  	reported  	 VBD	O
of  	of  	 IN	O
having  	having  	 VBG	O
had  	had  	 VBD	O
an  	an  	 DT	O
operation 	operation 	 NN	O
,  	,  	 ,	O
69.8 	69.8 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
37 	37 	 CD	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
them  	them  	 PRP	O
described  	described  	 VBD	O
postoperative  	postoperative  	 JJ	B-NP
bleedings  	bleedings  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
=  	=  	 SYM	O
0.0373 	0.0373 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
13.5 	13.5 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
5 	5 	 CD	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
54  	54  	 CD	O
could  	could  	 MD	O
remember  	remember  	 VB	O
having  	having  	 VBG	O
been  	been  	 VBN	O
randomly  	randomly  	 RB	O
treated  	treated  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
transfusion  	transfusion  	 NN	O
and  	and  	 CC	O
only  	only  	 RB	O
2.7 	2.7 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
by  	by  	 IN	O
substitution  	substitution  	 NN	B-NP
of  	of  	 IN	I-NP
von  	von  	 NNP	I-NP
Willebrand  	Willebrand  	 NNP	I-NP
factor.  	factor.  	 CD	I-NP
71 	71 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
51 	51 	 CD	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
indicated  	indicated  	 VBD	B-NP
haematoma  	haematoma  	 NNS	I-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
=  	=  	 SYM	O
0.8116 	0.8116 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
About  	About  	 IN	O
33.8 	33.8 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
24 	24 	 CD	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
gum  	gum  	 JJ	O
bleeding  	bleeding  	 NN	O
and  	and  	 CC	O
40.8 	40.8 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
29 	29 	 CD	O
,  	,  	 ,	O
p  	p  	 VBG	O
=  	=  	 SYM	O
0.7808 	0.7808 	 CD	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
reported  	reported  	 VBD	O
bleeding  	bleeding  	 VBG	O
after  	after  	 IN	O
the  	the  	 DT	O
dentist.  	dentist.  	 CD	O
41.4 	41.4 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
29 	29 	 CD	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
suffered  	suffered  	 VBD	O
under  	under  	 IN	O
frequent  	frequent  	 JJ	O
epistaxis  	epistaxis  	 NNS	B-NP
( 	( 	 -LRB-	O
p  	p  	 CD	O
=  	=  	 SYM	O
0.0212 	0.0212 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
prolonged  	prolonged  	 JJ	O
epinephrine  	epinephrine  	 NNS	B-NP
bleeding  	bleeding  	 VBG	I-NP
time  	time  	 NN	I-NP
to  	to  	 TO	O
VWF 	VWF 	 NNP	B-NP
: 	: 	 :	O
Ag  	Ag  	 NNP	B-NP
( 	( 	 -LRB-	O
rho  	rho  	 CD	B-NP
=  	=  	 SYM	O
0.16 	0.16 	 CD	O
)  	)  	 -RRB-	O
nor  	nor  	 CC	O
to  	to  	 TO	O
VWF 	VWF 	 NNP	B-NP
: 	: 	 :	O
RCo  	RCo  	 NNP	B-NP
( 	( 	 -LRB-	O
rho  	rho  	 CD	B-NP
=  	=  	 SYM	O
0.12 	0.12 	 CD	O
)  	)  	 -RRB-	O
nor  	nor  	 CC	O
between  	between  	 IN	O
prolonged  	prolonged  	 JJ	O
epinephrine  	epinephrine  	 NN	B-NP
and  	and  	 CC	O
ADP  	ADP  	 NNP	B-NP
bleeding  	bleeding  	 NN	I-NP
time  	time  	 NN	I-NP
( 	( 	 -LRB-	O
rho  	rho  	 CD	B-NP
=  	=  	 SYM	O
0.01 	0.01 	 CD	O
)  	)  	 -RRB-	O
nor  	nor  	 CC	O
to  	to  	 TO	O
ROTEM®  	ROTEM®  	 CD	B-NP
analysis 	analysis 	 NN	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
with  	with  	 IN	O
isolated  	isolated  	 JJ	O
prolonged  	prolonged  	 JJ	O
PFA  	PFA  	 NNS	B-NP
are  	are  	 VBP	O
mainly  	mainly  	 RB	O
women  	women  	 NNS	O
and  	and  	 CC	O
can  	can  	 MD	O
be  	be  	 VB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
all  	all  	 DT	O
kinds  	kinds  	 NNS	O
of  	of  	 IN	O
bleedings  	bleedings  	 NN	B-NP
while  	while  	 IN	O
haematoma  	haematoma  	 NN	B-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
main  	main  	 JJ	O
symptom 	symptom 	 NN	B-NP
.  	.  	 .	O
VWD  	VWD  	 NNP	B-NP
might  	might  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
causal 	causal 	 NNS	O
.  	.  	 .	O
